Clinical trial
A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC
NCT06511596 is registered in ClinicalTrials.gov with BioStem Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC
- Lead sponsor
- BioStem Technologies
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 3, 2024
- Completion date
- December 22, 2025
- Enrollment
- 71 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer